Clinical Trial Update: Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial is evaluating fetal cerebrovascular autoregulation in fetuses with congenital heart disease and its relation to neonatal neurob…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Hypoxia
• Neurodevelopmental Disorders

Snippet

Sponsor: University of Utah | Conditions: Congenital Heart Disease in Children, Hypoxia | Phase 2, Phase 3 | Status: RECRUITING